Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2026
|
| Materias: | |
| Acceso en línea: | https://onlinelibrary.wiley.com/doi/10.1111/echo.70429 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Tabla de Contenidos:
- PLAX‐Only M‐Mode Scoring System for Risk Stratification of Moderate‐to‐Severe Left Ventricular Diastolic Dysfunction: A Retrospective Diagnostic Study Jonghoon Yoo Taekwon Kim Kyungsub Song Sang‐hun Lee Hee Yoon Echocardiography ABSTRACT Background Doppler‐based diastolic dysfunction assessment requires optimal apical views and specialized expertise, and up to 30% of evaluations yield indeterminate results. We investigated whether a parasternal long‐axis (PLAX)–only M‐mode scoring system derived from mitral valve anterior leaflet (MVAL) motion could provide clinically useful risk stratification for moderate‐to‐severe left ventricular diastolic dysfunction (LVDD). Methods This retrospective study analyzed echocardiographic data from 253 patients. Novel M‐mode parameters (EPSS, APSS, EPOL, APOL, and their ratios) were compared with conventional Doppler indices across LVDD severity grades (normal, grade 1, grade 2, grade 3). A logistic regression‐based scoring system combining five M‐mode parameters was developed and internally evaluated using five‐fold cross‐validation with bootstrap confidence intervals. Results The EPOL/APOL ratio showed moderate correlations with the E/A ratio in both normal‐to‐mild ( r = 0.353, p < 0.001) and moderate‐to‐severe ( r = 0.397, p = 0.001) LVDD groups. The logistic regression–derived scoring system achieved an AUC of 0.754 (95% CI: 0.672–0.825), with 55.7% sensitivity and 85.9% specificity at the optimal cutoff of 63.5. Decision curve analysis demonstrated positive net benefit over default strategies across the clinically plausible threshold probability range of 0.15–0.35. Conclusion A PLAX‐only M‐mode scoring system provides acceptable discrimination and positive net clinical benefit for risk stratification of moderate‐to‐severe LVDD. External validation in independent populations is required before clinical implementation. 10.1111/echo.70429 http://creativecommons.org/licenses/by-nc-nd/4.0/